BackDaShenLin Pharmaceutical Group , Ltd. Overview

DaShenLin Pharmaceutical Group , Ltd. Current Assets

Latest current assets for 603233.SS: $13B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$12.79B
↑ 5.80% YoYΔ $701.79M vs prior year quarter

Peer trimmed avg / median

Loading

DaShenLin Pharmaceutical Group , Ltd. Current Assets History

Loading

DaShenLin Pharmaceutical Group , Ltd. vs. peers: Current Assets Comparison

Loading

DaShenLin Pharmaceutical Group , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DaShenLin Pharmaceutical Group , Ltd. (603233.SS) FAQ

As of the most recent data (June 2026), 603233.SS shows a current assets of $13B. That compares with $12B in the prior-year period — up 5.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603233.SS's current assets is now $13B (was $12B) — a 5.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether DaShenLin Pharmaceutical Group , Ltd. is outperforming or lagging.

Tracking 603233.SS's current assets over time shows whether DaShenLin Pharmaceutical Group , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $13B That compares with $12B in the prior-year period — up 5.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has DaShenLin Pharmaceutical Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $13B) with ownership activity and broader fundamentals.